肝脏
肝髒
간장
CHINESE HEPATOLOGY
2014年
7期
483-486
,共4页
药物性肝损伤%药物%发病因素
藥物性肝損傷%藥物%髮病因素
약물성간손상%약물%발병인소
Drug-induced liver injury%Drug%Etiologic factors
目的:探讨药物性肝损伤患者的临床特点及发病因素。方法回顾性分析药物性肝损伤患者服药史、临床表现、基础疾病、治疗及转归等。结果200例患者中女139例,男61例,涉及药品169种,其中前3位是中药(48.5%)、抗感染药(11.2%)、抗肿瘤药(8.2%)。患者基础疾病主要为心血管病(14.5%)、感染性疾病(10.3%)、皮肤病(8.8%)、骨关节病(8.4%)、肿瘤(7.9%)等。200例患者治愈146例,好转53例,死亡1例。结论引起肝损伤的药物以中药为主,临床表现形式多样,但转归较好。
目的:探討藥物性肝損傷患者的臨床特點及髮病因素。方法迴顧性分析藥物性肝損傷患者服藥史、臨床錶現、基礎疾病、治療及轉歸等。結果200例患者中女139例,男61例,涉及藥品169種,其中前3位是中藥(48.5%)、抗感染藥(11.2%)、抗腫瘤藥(8.2%)。患者基礎疾病主要為心血管病(14.5%)、感染性疾病(10.3%)、皮膚病(8.8%)、骨關節病(8.4%)、腫瘤(7.9%)等。200例患者治愈146例,好轉53例,死亡1例。結論引起肝損傷的藥物以中藥為主,臨床錶現形式多樣,但轉歸較好。
목적:탐토약물성간손상환자적림상특점급발병인소。방법회고성분석약물성간손상환자복약사、림상표현、기출질병、치료급전귀등。결과200례환자중녀139례,남61례,섭급약품169충,기중전3위시중약(48.5%)、항감염약(11.2%)、항종류약(8.2%)。환자기출질병주요위심혈관병(14.5%)、감염성질병(10.3%)、피부병(8.8%)、골관절병(8.4%)、종류(7.9%)등。200례환자치유146례,호전53례,사망1례。결론인기간손상적약물이중약위주,림상표현형식다양,단전귀교호。
Objective To investigate the characteristics and risk etiological factors of drug-induced liver injury(DILI) cases,and provide information for clinical prevention and treatment.Methods The clinical data of 200 patients (including 139 female and 71 male ) with DILI was retrospectively analyzed according to their history of medicine, clinical manifestations,underlying diseases,treatment and prognosis.Results These 200 cases involved 169 etiological drugs,of which the top 3 were traditional Chinese medicine,anti-infective drugs and anti-tumor drugs.The primary underlying diseases of these patients were cardiovascular disease,infectious diseases,skin diseases,osteoarthrosis,tumors and so on. Of those 200 patients,146 were cured,53 improved and 1 died.Conclusion DILI is dominated by traditional Chinese medicine,with various clinical manifestations and favorable prognosis.